DGCR2 Antibody - N-terminal regio: FITC (ARP46575_P050-FITC)

DiGeorge syndrome critical region gene 2

IDD, LAN, DGS-C, SEZ-12

9993

P98153

NP_005128

Human, Mouse, Rat, Cow, Dog, Guinea Pig, Horse

The immunogen is a synthetic peptide directed towards the N terminal region of human DGCR2

Deletions of the 22q11.2 have been associated with a wide range of developmental defects (notably DiGeorge syndrome, velocardiofacial syndrome, conotruncal anomaly face syndrome and isolated conotruncal cardiac defects) classified under the acronym CATCH 22. The DGCR2 gene encodes a novel putative adhesion receptor protein, which could play a role in neural crest cells migration, a process which has been proposed to be altered in DiGeorge syndrome. Alternative splicing results in multiple transcript variants.

HNRNPD; SMURF2; DDIT3

FITC: Fluorescein Isothiocyanate

Polyclonal Antibody

WB

Affinity Purified

DGCR2 is strongly supported by BioGPS gene expression data to be expressed in SHSY5Y

0.5 mg/ml

Cow: 100%; Dog: 100%; Guinea Pig: 100%; Horse: 93%; Human: 100%; Mouse: 100%; Rat: 100%

Liquid. Purified antibody supplied in 1x PBS buffer.

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.

61kDa

Olsen, J.V., (2006) Cell 127 (3), 635-648

Wet Ice

550

DGCR2

DGCR2

Rabbit

Integral membrane protein DGCR2/IDD

NM_005137

MVPKADSGAFLLLFLLVLTVTEPLRPELRCNPGQFACRSGTIQCIPLPWQ